Atlas Trials

Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA

Clinical trial NCT02629523 · COMPLETED

Trial details

NCT number
NCT02629523
Sponsor
Chonnam National University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung NeoplasmsEGFR Gene Mutation
Start date
2016-06-01
Primary completion
2018-12-31
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.